Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | TSC1 |
Variant | R500* |
Impact List | nonsense |
Protein Effect | loss of function - predicted |
Gene Variant Descriptions | TSC1 R500* results in a premature truncation of the Tsc1 protein at amino acid 500 of 1164 (UniProt.org). R500* has not been characterized however, due to the effects of other truncation mutations downstream of R500 (PMID: 11875047, PMID: 20547222), is predicted to lead to a loss of Tsc1 protein function. |
Associated Drug Resistance | |
Category Variants Paths |
TSC1 mutant TSC1 inact mut TSC1 R500* |
Transcript | NM_000368.5 |
gDNA | chr9:g.132906080G>A |
cDNA | c.1498C>T |
Protein | p.R500* |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_000368.4 | chr9:g.132906080G>A | c.1498C>T | p.R500* | RefSeq | GRCh38/hg38 |
XM_017015096.1 | chr9:g.132906080G>A | c.1498C>T | p.R500* | RefSeq | GRCh38/hg38 |
NM_001406605.1 | chr9:g.132906080G>A | c.1498C>T | p.R500* | RefSeq | GRCh38/hg38 |
NM_001406623.1 | chr9:g.132905713_132905714delAGinsTA | c.1498_1499delAGinsTA | p.R500* | RefSeq | GRCh38/hg38 |
XM_005272211 | chr9:g.132906080G>A | c.1498C>T | p.R500* | RefSeq | GRCh38/hg38 |
XM_011518979.3 | chr9:g.132906080G>A | c.1498C>T | p.R500* | RefSeq | GRCh38/hg38 |
XM_017015096 | chr9:g.132906080G>A | c.1498C>T | p.R500* | RefSeq | GRCh38/hg38 |
NM_001406606.1 | chr9:g.132906080G>A | c.1498C>T | p.R500* | RefSeq | GRCh38/hg38 |
NM_001406602.1 | chr9:g.132906080G>A | c.1498C>T | p.R500* | RefSeq | GRCh38/hg38 |
NM_001406593.1 | chr9:g.132906080G>A | c.1498C>T | p.R500* | RefSeq | GRCh38/hg38 |
NM_001406601.1 | chr9:g.132906080G>A | c.1498C>T | p.R500* | RefSeq | GRCh38/hg38 |
NM_000368.5 | chr9:g.132906080G>A | c.1498C>T | p.R500* | RefSeq | GRCh38/hg38 |
XM_006717271 | chr9:g.132906080G>A | c.1498C>T | p.R500* | RefSeq | GRCh38/hg38 |
NM_001406592.1 | chr9:g.132906080G>A | c.1498C>T | p.R500* | RefSeq | GRCh38/hg38 |
XM_011518979.2 | chr9:g.132906080G>A | c.1498C>T | p.R500* | RefSeq | GRCh38/hg38 |
XM_017015097.1 | chr9:g.132906080G>A | c.1498C>T | p.R500* | RefSeq | GRCh38/hg38 |
NM_001406607.1 | chr9:g.132906080G>A | c.1498C>T | p.R500* | RefSeq | GRCh38/hg38 |
NM_001406622.1 | chr9:g.132905713_132905714delAGinsTA | c.1498_1499delAGinsTA | p.R500* | RefSeq | GRCh38/hg38 |
XM_017015097 | chr9:g.132906080G>A | c.1498C>T | p.R500* | RefSeq | GRCh38/hg38 |
XM_005272211.1 | chr9:g.132906080G>A | c.1498C>T | p.R500* | RefSeq | GRCh38/hg38 |
XM_017015101.1 | chr9:g.132905713_132905714delAGinsTA | c.1498_1499delAGinsTA | p.R500* | RefSeq | GRCh38/hg38 |
XM_017015101 | chr9:g.132905713_132905714delCTinsTA | c.1498_1499delAGinsTA | p.R500* | RefSeq | GRCh38/hg38 |
NM_001406621.1 | chr9:g.132905713_132905714delAGinsTA | c.1498_1499delAGinsTA | p.R500* | RefSeq | GRCh38/hg38 |
XM_006717271.1 | chr9:g.132906080G>A | c.1498C>T | p.R500* | RefSeq | GRCh38/hg38 |
XM_011518979 | chr9:g.132906080G>A | c.1498C>T | p.R500* | RefSeq | GRCh38/hg38 |
NM_001406625.1 | chr9:g.132905713_132905714delAGinsTA | c.1498_1499delAGinsTA | p.R500* | RefSeq | GRCh38/hg38 |
NM_000368 | chr9:g.132906080G>A | c.1498C>T | p.R500* | RefSeq | GRCh38/hg38 |
NM_001406595.1 | chr9:g.132906080G>A | c.1498C>T | p.R500* | RefSeq | GRCh38/hg38 |
NM_001406596.1 | chr9:g.132906080G>A | c.1498C>T | p.R500* | RefSeq | GRCh38/hg38 |
NM_001406594.1 | chr9:g.132906080G>A | c.1498C>T | p.R500* | RefSeq | GRCh38/hg38 |
NM_001406620.1 | chr9:g.132905713_132905714delAGinsTA | c.1498_1499delAGinsTA | p.R500* | RefSeq | GRCh38/hg38 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|